ARBB Arbuthnot Banking Group

Q&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends

Hardman & Co Research
Q&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends

22-Apr-2024 / 15:49 GMT/BST
The issuer is solely responsible for the content of this announcement.


Hardman & Co analyst interview | Banks

Q&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends

Arbuthnot Banking Group (LON:ARBB) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews.

Mark discusses his recent research note highlighting Arbuthnot’s successful financial year, noting a significant increase in pre-tax profit, operating income and net assets, alongside improvements in earnings per share and dividends. Mark explains how Arbuthnot has strategically positioned itself to thrive in a rising rate environment by adjusting the duration of its securities and increasing fixed-rate SME finance, preparing it for potential rate declines. He touches on the progress made in Arbuthnot's SME financing franchises, with notable profit increases and loan book growth.

Despite a challenging macroeconomic landscape, the bank’s cautious approach has ensured sustained high credit quality with minimal impairments. The discussion also addresses concerns about net interest margins and inflationary pressures on costs, with an emphasis on the conservative management of the bank’s lending practices to mitigate credit risks.

Arbuthnot Banking Group is a holding company for Arbuthnot Latham & Co.; it offers carefully crafted expert private and commercial banking services alongside wealth planning advice from Chartered Wealth Planners and discretionary investment management.

Listen to the interview .

 

If you are interested in meeting the company, you can register your interest

To contact us:

Hardman & Co
9 Bonhill Street

London

EC2A 4DJ

Follow us on Twitter @HardmanandCo

Analyst:

Mark Thomas



 

 



 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

 



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1886281  22-Apr-2024 

fncls.ssp?fn=show_t_gif&application_id=1886281&application_name=news&site_id=research_pool
EN
22/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arbuthnot Banking Group

Mark Thomas
  • Mark Thomas

Arbuthnot Banking Group - 2024 results: franchise growing through the ...

The core of any successful, long-term business lies in offering clients the products they want so that they give you more business and, in turn, you attract new customers. The 2024 results show how ABG has achieved this, with growth in i) specialist lending (now £828m, 35% of loans up 33% in 2023, 27% in 2022 and 21% in 2021), ii) deposit volumes (+10%), and iii) wealth management (FUMA +30%). 1,200 new banking clients were onboarded in 2024. Short-term profits reflected that ABG had optimised r...

 PRESS RELEASE

Hardman & Co Research: Arbuthnot Banking Group - 2024 results: franchi...

Hardman & Co Research Hardman & Co Research: Arbuthnot Banking Group - 2024 results: franchise growing through the noise 04-Apr-2025 / 16:00 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on Arbuthnot Banking Group (ARBB): 2024 results: franchise growing through the noise   The core of any successful, long-term business lies in offering clients the products they want so that they give you more business and, in turn, you attract new customers. The 2024 results show how ABG has achieved this, with growth in i) specialist len...

Mark Thomas ... (+2)
  • Mark Thomas
  • Martin Hall

Hardman & Co Monthly: April 2025

Feature article: 2024 pharma statistics An efficient reporting system has seen all the listed multinational pharmaceutical companies announce results for 2024, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of global pharmaceutical market growth plus the global and US company rankings for 2024. The year was characterised by 9.2% underlying (ex-COVID-19) growth. Much of the growth was driven by recently launched ant...

Mark Thomas ... (+2)
  • Mark Thomas
  • Nigel Hawkins

Hardman & Co Monthly: March 2025

In this month's feature article, we review the energy situation in the UK. On the domestic front, Ofgem has recently announced the new price cap figure of £1,849 for a typical household’s annual use of gas and electricity; this figure represents an increase of 6.4% over the January-March 2025 price cap. UK energy policy has changed of late, following the election of a Labour government last summer. The quest for Net Zero by 2030 – a hardly realistic target – is now a priority. Rightly or wrong...

Keith Hiscock ... (+2)
  • Keith Hiscock
  • Mark Thomas

Hardman & Co Monthly: February 2025

Feature article: The October 2024 Budget - We got it wrong By Keith Hiscock, CEO at Hardman & Co In this month's feature article, we review the effects of the 2024 Budget and consider what might happen in the coming months. Our Hardman Monthly of October 2024 looked forward to the first Labour Budget for 14 years. The main theme was that, because the new Chancellor, Rachel Reeves, had ruled out increases in taxes on ‘working people’, investors would bear the brunt of any tax increases to fill ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch